Selective HDAC Inhibition for the Disruption of Latent HIV-1 Infection
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Selective HDAC Inhibition for the Disruption of Latent HIV-1 Infection
Authors
Keywords
-
Journal
PLoS One
Volume 9, Issue 8, Pages e102684
Publisher
Public Library of Science (PLoS)
Online
2014-08-20
DOI
10.1371/journal.pone.0102684
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- BET bromodomain-targeting compounds reactivate HIV from latency via a Tat-independent mechanism
- (2013) Daniela Boehm et al. CELL CYCLE
- Signal-dependent repression of DUSP5 by class I HDACs controls nuclear ERK activity and cardiomyocyte hypertrophy
- (2013) B. S. Ferguson et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- An In-Depth Comparison of Latent HIV-1 Reactivation in Multiple Cell Model Systems and Resting CD4+ T Cells from Aviremic Patients
- (2013) Celsa A. Spina et al. PLoS Pathogens
- BET bromodomain inhibition as a novel strategy for reactivation of HIV-1
- (2012) Camellia Banerjee et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Inhibitors of Histone Deacetylases
- (2011) Kelly Huber et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Nuclear Receptor Signaling Inhibits HIV-1 Replication in Macrophages through Multiple trans-Repression Mechanisms
- (2011) T. M. Hanley et al. JOURNAL OF VIROLOGY
- Physiological Roles of Class I HDAC Complex and Histone Demethylase
- (2010) Tomohiro Hayakawa et al. JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY
- Selective Inhibition of Histone Deacetylases Sensitizes Malignant Cells to Death Receptor Ligands
- (2010) T. E. Wood et al. MOLECULAR CANCER THERAPEUTICS
- Expression of latent human immunodeficiency type 1 is induced by novel and selective histone deacetylase inhibitors
- (2009) Nancie M Archin et al. AIDS
- Short Communication: Activation of Latent HIV Type 1 Gene Expression by Suberoylanilide Hydroxamic Acid (SAHA), an HDAC Inhibitor Approved for Use to Treat Cutaneous T Cell Lymphoma
- (2009) Leonard C. Edelstein et al. AIDS RESEARCH AND HUMAN RETROVIRUSES
- Expression of Latent HIV Induced by the Potent HDAC Inhibitor Suberoylanilide Hydroxamic Acid
- (2009) Nancie M. Archin et al. AIDS RESEARCH AND HUMAN RETROVIRUSES
- Determinants of the Establishment of Human Immunodeficiency Virus Type 1 Latency
- (2009) A. Duverger et al. JOURNAL OF VIROLOGY
- A Limited Group of Class I Histone Deacetylases Acts To Repress Human Immunodeficiency Virus Type 1 Expression
- (2009) K. S. Keedy et al. JOURNAL OF VIROLOGY
- Synergistic Activation of HIV-1 Expression by Deacetylase Inhibitors and Prostratin: Implications for Treatment of Latent Infection
- (2009) Sophie Reuse et al. PLoS One
- "Shock and kill" effects of class I-selective histone deacetylase inhibitors in combination with the glutathione synthesis inhibitor buthionine sulfoximine in cell line models for HIV-1 quiescence
- (2009) Andrea Savarino et al. Retrovirology
- Hexamethylbisacetamide and Disruption of Human Immunodeficiency Virus Type 1 Latency in CD4+T Cells
- (2008) Shailesh K. Choudhary et al. JOURNAL OF INFECTIOUS DISEASES
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started